In the model group and PD-L1 inhibitor treatment group, the tumor volumes and weights in the mice were lower in the PD-L1 inhibitor group compared with the model group, suggesting that PD-L1 inhibitors suppressed tumor growth in a nude mouse model of hypopharyngeal carcinoma. The gene discussed is CD274; the disease is neoplasm.